SterisCare Pharma is proud to announce that our manufacturing facility has successfully passed the WHO-GMP (World Health Organization – Good Manufacturing Practices) audit for Financial Year 2025-26, reconfirming our certification to manufacture and export pharmaceutical products to global markets.
The audit, conducted over three days by a team of independent WHO-accredited inspectors, covered all critical areas of our manufacturing operations — including quality control laboratories, production suites, environmental monitoring systems, documentation practices, and personnel hygiene protocols.
Audit Highlights
The inspection team reviewed our documentation systems, sampling procedures, stability testing protocols, and batch release processes. Key observations from the audit team included:
- Zero critical deviations across all inspected areas.
- Commendable implementation of electronic batch record management.
- Robust supplier qualification programme for active pharmaceutical ingredients.
- Consistent environmental monitoring results well within action limits.
What This Means for Our Partners
For our international distribution partners and hospital procurement teams, this recertification confirms that every SterisCare product you source meets the stringent quality benchmarks required by WHO and accepted by regulatory authorities across 40+ countries.
This achievement reaffirms our long-standing commitment to quality-first manufacturing. We look forward to continuing to serve our partners with medicines that meet global standards.
